Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study

NCT06350461 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

370

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

OTHER: Discontinuation of hypertonic saline (HS)
OTHER: Continuation of hypertonic saline (HS)

Sponsor

Nicole Hamblett

Collaborators

[object Object]
[object Object]
[object Object]